These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 16445548)

  • 21. Self-management improves outcomes in persons with limb loss.
    Wegener ST; Mackenzie EJ; Ephraim P; Ehde D; Williams R
    Arch Phys Med Rehabil; 2009 Mar; 90(3):373-80. PubMed ID: 19254599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensive referral to 12-Step self-help groups and 6-month substance use disorder outcomes.
    Timko C; Debenedetti A; Billow R
    Addiction; 2006 May; 101(5):678-88. PubMed ID: 16669901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis of psychological interventions to promote adherence to treatment in pediatric chronic health conditions.
    Kahana S; Drotar D; Frazier T
    J Pediatr Psychol; 2008 Jul; 33(6):590-611. PubMed ID: 18192300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized trial of onsite versus referral primary medical care for veterans in addictions treatment.
    Saxon AJ; Malte CA; Sloan KL; Baer JS; Calsyn DA; Nichol P; Chapko MK; Kivlahan DR
    Med Care; 2006 Apr; 44(4):334-42. PubMed ID: 16565634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What role does measuring medication compliance play in evaluating the efficacy of naltrexone?
    Baros AM; Latham PK; Moak DH; Voronin K; Anton RF
    Alcohol Clin Exp Res; 2007 Apr; 31(4):596-603. PubMed ID: 17374038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral strategies to improve treatment participation and retention by pregnant drug-dependent women.
    Svikis DS; Silverman K; Haug NA; Stitzer M; Keyser-Marcus L
    Subst Use Misuse; 2007; 42(10):1527-35. PubMed ID: 17918023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreasing effect sizes for effectiveness studies- implications for the transport of evidence-based treatments: comment on curtis, ronan, and borduin (2004).
    Henggeler SW
    J Fam Psychol; 2004 Sep; 18(3):420-3. PubMed ID: 15382966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pilot double-blind treatment trial of memantine for alcohol dependence.
    Evans SM; Levin FR; Brooks DJ; Garawi F
    Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resets do not appear to increase the rate of adverse events or prolong relapse in voucher-based reinforcement therapy.
    Versek BE; Carpenedo CM; Rosenwasser BJ; Dugosh KL; Bresani E; Kirby KC
    J Subst Abuse Treat; 2010 Sep; 39(2):167-73. PubMed ID: 20598837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms.
    Mercer D; Douglass AB; Links PS
    J Pers Disord; 2009 Apr; 23(2):156-74. PubMed ID: 19379093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Internet-based abstinence reinforcement treatment for cigarette smoking.
    Dallery J; Glenn IM; Raiff BR
    Drug Alcohol Depend; 2007 Jan; 86(2-3):230-8. PubMed ID: 16930854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Voucher-based incentives. A substance abuse treatment innovation.
    Higgins ST; Alessi SM; Dantona RL
    Addict Behav; 2002; 27(6):887-910. PubMed ID: 12369474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A tale of two cities: financing two voucher programs for substance abusers through community donations.
    Amass L; Kamien J
    Exp Clin Psychopharmacol; 2004 May; 12(2):147-55. PubMed ID: 15122959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impulsivity and voucher versus money preference in polydrug-dependent participants enrolled in a contingency-management-based substance abuse treatment program.
    Reilly MP; Roll JM; Downey KK
    J Subst Abuse Treat; 2000 Oct; 19(3):253-7. PubMed ID: 11027895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical implications of reinforcement as a determinant of substance use disorders.
    Higgins ST; Heil SH; Lussier JP
    Annu Rev Psychol; 2004; 55():431-61. PubMed ID: 14744222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving client compliance in outpatient treatment: counselor-targeted interventions.
    McCaul ME; Svikis DS
    NIDA Res Monogr; 1991; 106():204-17. PubMed ID: 1922288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cash value of voucher reinforcers in pregnant drug-dependent women.
    Rosado J; Sigmon SC; Jones HE; Stitzer ML
    Exp Clin Psychopharmacol; 2005 Feb; 13(1):41-7. PubMed ID: 15727502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contingency management voucher redemption as an indicator of delayed gratification.
    Fletcher JB; Dierst-Davies R; Reback CJ
    J Subst Abuse Treat; 2014 Jul; 47(1):73-7. PubMed ID: 24674235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic review of reinforcement-based interventions for substance use: Efficacy, mechanisms of action, and moderators of treatment effects.
    Fazzino TL; Bjorlie K; Lejuez CW
    J Subst Abuse Treat; 2019 Sep; 104():83-96. PubMed ID: 31370989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Voucher-based incentives for naltrexone treatment attendance in schizophrenia and alcohol use disorders.
    Leontieva L; Dimmock JA; Gately PW; Gallinger L; Ploutz-Snyder R; Batki SL
    Psychiatr Serv; 2008 Mar; 59(3):310-4. PubMed ID: 18308913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.